IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients

Clinical Chemistry

Volumn 43, Issue 10, 1997, Pages 1989-1991

  Wallemacq, Pierre E ^a   Leal, Teresinha ^a   Besse, Tatiana ^a   Squifflet, Jean Paul ^a   Reding, Raymond ^a   Otte, Jean Bernard ^a   Lerut, Jan ^a   Hassoun, Alexandre ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; HUMAN; IMMUNOMODULATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MICROPARTICLE ENZYME IMMUNOASSAY;

EID: 0030774653     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.10.1989     Document Type: Article

References (5)

1. Grenier FC, Luczkiw J, Bergmann M, Lunetta S, Morrison M, Blonski D, et al. A whole blood FK 506 assay for the IMx analyzer. Transplant Proc 1991;23: 2748-9.
2. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, et al. FK 506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation and physicochemical and biological characteristics. J Antibiot 1987;40:1249-55.
3. Wallemacq PE, Reding R. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects [Review]. Clin Chem 1993;39:2219-28.
4. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
5. Wallemacq PE, Firdaous I, Hassoun A. Improvement and assessment of enzyme-linked immunosorbent assay to detect low FK506 concentrations in plasma or whole blood within 6 h. Clin Chem 1993;39:1045-9.